Avi Eliassaf
Geschäftsführer bei Anima Biotech, Inc.
Profil
Avi Eliassaf is currently the Chief Operating Officer at Anima Biotech, Inc. Previously, he worked as the Chief Financial Officer at SalesPredict SW Ltd.
He completed his undergraduate degree at Ben-Gurion University of the Negev.
Aktive Positionen von Avi Eliassaf
| Unternehmen | Position | Beginn |
|---|---|---|
Anima Biotech, Inc.
 Anima Biotech, Inc. Pharmaceuticals: MajorHealth Technology Anima Biotech, Inc. develops translation control therapeutics, a new class of drugs that specifically control protein translation as a novel strategy against hard and undruggable targets. The firm?s platform combines new biology with proprietory image analysis and big data software. The company was founded Yochi Slonim and Zeev Smilansky and is headquartered in Bernardsville, NJ. | Geschäftsführer | - |
Ehemalige bekannte Positionen von Avi Eliassaf
| Unternehmen | Position | Ende |
|---|---|---|
SalesPredict SW Ltd.
 SalesPredict SW Ltd. Electronics DistributorsDistribution Services SalesPredict SW Ltd. developed predictive analytics solutions. The firm offered solution for marketing, sale and customer management. The company was founded by Yaron Zakai-Or and Kira Radinsky in 2012 and was headquartered in Netanya, Israel. | Finanzdirektor/CFO | - |
Ausbildung von Avi Eliassaf
| Ben-Gurion University of the Negev | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 2 |
|---|---|
SalesPredict SW Ltd.
SalesPredict SW Ltd. Electronics DistributorsDistribution Services SalesPredict SW Ltd. developed predictive analytics solutions. The firm offered solution for marketing, sale and customer management. The company was founded by Yaron Zakai-Or and Kira Radinsky in 2012 and was headquartered in Netanya, Israel. | Distribution Services |
Anima Biotech, Inc.
Anima Biotech, Inc. Pharmaceuticals: MajorHealth Technology Anima Biotech, Inc. develops translation control therapeutics, a new class of drugs that specifically control protein translation as a novel strategy against hard and undruggable targets. The firm?s platform combines new biology with proprietory image analysis and big data software. The company was founded Yochi Slonim and Zeev Smilansky and is headquartered in Bernardsville, NJ. | Health Technology |
